Original Source(s)
Related Content
Roswell Park Study: Inhibiting Regulator Protein Can Make Aggressive Prostate Cancers More Vulnerable
Team shows BCL-2 promotes treatment resistance, uncovering strategy for making tumors respond to treatment.
New Research Sheds Light on How Precancerous Lesions Form in the Pancreas
Discoveries about two metabolic enzymes could point the way to biomarkers, opportunities to prevent cancer.
Roswell Park Experts Highlight Untapped Potential of CDK Inhibitor Cancer Therapy
Worldwide, more than a million breast cancer patients have been treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, which slow or stop the uncontrolled multiplication of cancer cells.
